FDA.reportPublic FDA data

Zoryve 0.3 % Topical Foam

RxCUI
2671684
RxNorm name
Zoryve 0.3 % Topical Foam
Display name
Zoryve 0.3 % Topical Foam
Full name
Zoryve 0.3 % Topical Foam
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f9e0b4a9-a227-4947-b00c-41fb18d16589ZORYVE 0.3 % Topical Foam [PSN] · roflumilast 3 MG/ML Topical Foam [Zoryve] [SBD] · Zoryve 0.3 % Topical Foam [SY] · Zoryve 3 MG/ML Topical Foam [SY]46These highlights do not include all the information needed to use ZORYVE foam, 0.3%, safely and effectively. See full prescribing information for ZORYVE foam, 0.3%. ZORYVE ® (roflumilast) topical foam, 0.3% Initial U.S. Approval: 201120260130